Emergent BioSolutions (EBS) Stock Forecast for 2024–2028. Sell or Buy Prediction
All stock predictions
All currency forecasts
All cryptocurrency predictions

This Month Predictions for EBS stock
Emergent BioSolutions Inc. Analysis
EBS Stock News


Popular stocks:
Suncor Energy
Amazon
Energy Transfer
Square
Etsy
Micron

TOP Stocks:
Microsoft
Apple
Tesla
Alibaba
Amazon
American Airlines
NVIDIA
Adobe

Shares of other companies:
DaVita
Vir Biotechnology
A. O. Smith
The Charles Schwab
Rattler Midstream
Conagra Brands
SAP SE
Digital World Acquisition
Cepton
Barrick Gold


Financial News

Popular Stocks Analysis

Helpful Highlights
Improve Your Financial Status: A How-To Guide

April 12, 2024 Improve Your Financial Status: A How-To Guide

Navigating through the complexities of personal finance can often feel like walking through a maze blindfolded. This guide is crafted especially for you,…
How ZIM Integrated Container Tracking is Revolutionizing Global Trade

April 12, 2024 How ZIM Integrated Container Tracking is Revolutionizing Global Trade

Have you ever wondered how your online shopping packages get to you? A big part of the answer is ZIM Integrated Container Tracking.…
6 Best Growth Stocks To Buy Now According to Metatrader 5

March 15, 2024 6 Best Growth Stocks To Buy Now According to Metatrader 5

One of the reasons investors prefer growth stocks is that they are expected to perform better than other companies in terms of sales…
Navigating GBP Forecast: Mistakes To Avoid In Forex Trading

March 6, 2024 Navigating GBP Forecast: Mistakes To Avoid In Forex Trading

Human error is common in forex trading and often leads to familiar trading issues. These trading mishaps lead to significant novice traders regularly. …
  1. Home
    2. »
  2. Stock forecasts
    3. »
  3. EBS

Emergent BioSolutions (EBS) Stock Forecast for 2024–2028. Sell or Buy?

Updated: April 19, 2024 (10:05)

Sector: Healthcare

The share price of Emergent BioSolutions Inc. (EBS) now

Latest session on the 19th of April for
Emergent BioSolutions Inc. is positive
Trading Volume: 924755
Open: 1.84 /  High: 2.06 /  Low: 1.84
What analysts predict: $5
52-week High/Low: $12.01 / $1.42

50/200 Day Moving Average: $2.35 / $3.399

This figure corresponds to the Average Price over the previous 50/200 days. For Emergent BioSolutions stocks, the 50-day moving average is the resistance level today.

For Emergent BioSolutions stocks, the 200-day moving average is the resistance level today.

Are you interested in Emergent BioSolutions Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Emergent BioSolutions stock price in 2024, 2025, 2026, 2027, 2028. How much will one Emergent BioSolutions share be worth in 2024 - 2028?

When should I take profit in Emergent BioSolutions stock? When should I record a loss on Emergent BioSolutions stock? What are analysts' forecasts for Emergent BioSolutions stock? What is the future of Emergent BioSolutions stock? We forecast Emergent BioSolutions stock performance using neural networks based on historical data on Emergent BioSolutions stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

Emergent BioSolutions stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2024, 2025, 2026, 2027 and 2028) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Emergent BioSolutions shares. This happens once a day.


Historical and forecast chart of Emergent BioSolutions stock

The chart below shows the historical price of Emergent BioSolutions stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Emergent BioSolutions stock price can be found in the table below.

Long-term forecasts by years.

Emergent BioSutions Inc. is a global biopharmaceutical company that develops, manufactures and provides a portfolio of medical countermeasures for biological and chemical threats, as well as emerging infectious diseases for hospitals and clinics.

Official site of the company

Emergent BioSolutions daily forecast for a month

Date Target Pes. Opt. Vol., %
Apr 21 1.90 1.86 1.93 4.14
Apr 22 1.90 1.86 1.94 3.92
Apr 23 1.85 1.81 1.87 3.37
Apr 24 1.81 1.78 1.84 3.31
Apr 25 1.78 1.76 1.82 2.99
Apr 26 1.81 1.77 1.85 4.34
Apr 27 1.82 1.78 1.84 3.74
Apr 28 1.84 1.80 1.85 2.88
Apr 29 1.88 1.83 1.92 4.96
Apr 30 1.90 1.86 1.92 3.13
May 01 1.88 1.84 1.89 2.92
May 02 1.91 1.87 1.95 4.29
May 03 1.94 1.90 1.99 4.34
May 04 1.91 1.88 1.94 3.42
May 05 1.90 1.89 1.93 2.43
May 06 1.95 1.91 2.00 4.55
May 07 1.93 1.90 1.98 4.23
May 08 1.99 1.97 2.02 2.40
May 09 2.01 1.99 2.06 3.57
May 10 1.96 1.94 2.01 3.68
May 11 1.98 1.95 2.01 2.72
May 12 1.94 1.89 1.98 4.88
May 13 1.99 1.96 2.04 4.10
May 14 1.97 1.92 1.99 3.58
May 15 1.97 1.96 1.99 1.44
May 16 1.96 1.95 1.98 1.85
May 17 2.00 1.97 2.01 2.10
May 18 2.03 2.00 2.08 4.04
May 19 2.02 1.97 2.06 4.52
May 20 1.97 1.96 2.00 2.19

Emergent BioSolutions Daily Price Targets


Emergent BioSolutions Stock Forecast 04-21-2024.

Forecast target price for 04-21-2024: $1.90.
Positive dynamics for Emergent BioSolutions shares will prevail with possible volatility of 3.977%.
Pessimistic target level: 1.86
Optimistic target level: 1.93

Emergent BioSolutions Stock Forecast 04-22-2024.

Forecast target price for 04-22-2024: $1.90.
Negative dynamics for Emergent BioSolutions shares will prevail with possible volatility of 3.768%.
Pessimistic target level: 1.86
Optimistic target level: 1.94

Emergent BioSolutions Stock Forecast 04-23-2024.

Forecast target price for 04-23-2024: $1.85.
Negative dynamics for Emergent BioSolutions shares will prevail with possible volatility of 3.258%.
Pessimistic target level: 1.81
Optimistic target level: 1.87

Emergent BioSolutions Stock Forecast 04-24-2024.

Forecast target price for 04-24-2024: $1.81.
Negative dynamics for Emergent BioSolutions shares will prevail with possible volatility of 3.206%.
Pessimistic target level: 1.78
Optimistic target level: 1.84

Emergent BioSolutions Stock Forecast 04-25-2024.

Forecast target price for 04-25-2024: $1.78.
Negative dynamics for Emergent BioSolutions shares will prevail with possible volatility of 2.906%.
Pessimistic target level: 1.76
Optimistic target level: 1.82

Emergent BioSolutions Stock Forecast 04-26-2024.

Forecast target price for 04-26-2024: $1.81.
Positive dynamics for Emergent BioSolutions shares will prevail with possible volatility of 4.164%.
Pessimistic target level: 1.77
Optimistic target level: 1.85

EBS (EBS) Monthly Stock Prediction for 2024

Month Target Pes. Opt. Vol., %
May. 2.21 2.09 2.25 7.02
Jun. 2.38 2.28 2.49 8.62
Jul. 2.49 2.35 2.59 9.38
Aug. 2.48 2.34 2.55 8.24
Sep. 2.54 2.42 2.71 10.80
Oct. 2.69 2.56 2.80 8.58
Nov. 2.78 2.60 2.90 10.27
Dec. 2.89 2.76 3.07 9.91
Full forecast for 2024

Emergent BioSolutions forecast for this year


Emergent BioSolutions Stock Prediction for May 2024

An uptrend is forecast for this month with an optimal target price of $2.20943. Pessimistic: $2.09. Optimistic: $2.25


Emergent BioSolutions Stock Prediction for Jun 2024

An uptrend is forecast for this month with an optimal target price of $2.38409. Pessimistic: $2.28. Optimistic: $2.49


Emergent BioSolutions Stock Prediction for Jul 2024

An uptrend is forecast for this month with an optimal target price of $2.49273. Pessimistic: $2.35. Optimistic: $2.59


Emergent BioSolutions Stock Prediction for Aug 2024

An downtrend is forecast for this month with an optimal target price of $2.48346. Pessimistic: $2.34. Optimistic: $2.55


Emergent BioSolutions Stock Prediction for Sep 2024

An uptrend is forecast for this month with an optimal target price of $2.5412. Pessimistic: $2.42. Optimistic: $2.71


Emergent BioSolutions Stock Prediction for Oct 2024

An uptrend is forecast for this month with an optimal target price of $2.68772. Pessimistic: $2.56. Optimistic: $2.80


Emergent BioSolutions Stock Prediction for Nov 2024

An uptrend is forecast for this month with an optimal target price of $2.78021. Pessimistic: $2.60. Optimistic: $2.90


Emergent BioSolutions Stock Prediction for Dec 2024

An uptrend is forecast for this month with an optimal target price of $2.89139. Pessimistic: $2.76. Optimistic: $3.07



Emergent BioSolutions (EBS) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Jan 2.85 2.67 2.91 8.54
Feb 2.62 2.47 2.73 9.70
Mar 2.50 2.44 2.55 4.64
Apr 2.54 2.37 2.64 10.27
May 2.49 2.37 2.65 10.57
Jun 2.54 2.47 2.68 7.85
Jul 2.69 2.61 2.89 9.78
Aug 2.64 2.56 2.77 7.43
Sep 2.62 2.48 2.72 8.70
Oct 2.73 2.60 2.90 10.07
Nov 2.71 2.56 2.89 11.57
Dec 2.58 2.43 2.65 8.41
Full forecast for 2025

Emergent BioSolutions (EBS) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 2.60 2.43 2.64 8.31
Feb 2.52 2.34 2.68 12.57
Mar 2.37 2.24 2.45 8.54
Apr 2.58 2.51 2.67 6.19
May 2.82 2.71 3.00 9.60
Jun 2.80 2.62 2.94 10.88
Jul 2.68 2.53 2.74 7.71
Aug 2.64 2.56 2.71 5.34
Sep 2.44 2.33 2.60 10.56
Oct 2.46 2.28 2.57 11.24
Nov 2.36 2.27 2.46 7.70
Dec 2.37 2.25 2.53 10.97
Full forecast for 2026

Emergent BioSolutions (EBS) Monthly Stock Prediction for 2027

Month Target Pes. Opt. Vol., %
Jan 2.41 2.24 2.48 9.48
Feb 2.51 2.44 2.63 7.19
Mar 2.43 2.31 2.52 8.23
Apr 2.40 2.30 2.49 7.53
May 2.45 2.40 2.59 7.30
Jun 2.51 2.37 2.60 9.07
Jul 2.60 2.42 2.78 12.90
Aug 2.60 2.54 2.68 5.42
Sep 2.55 2.45 2.73 10.15
Oct 2.45 2.37 2.58 7.86
Nov 2.37 2.33 2.48 6.31
Dec 2.55 2.47 2.68 7.87
Full forecast for 2027

Emergent BioSolutions (EBS) Monthly Stock Prediction for 2028

Month Target Pes. Opt. Vol., %
Jan 2.62 2.56 2.67 4.20
Feb 2.58 2.50 2.62 4.84
Mar 2.64 2.49 2.73 8.71
Apr 2.72 2.65 2.79 4.99
May 2.73 2.60 2.89 9.77
Jun 2.90 2.68 3.09 13.16
Jul 3.14 3.04 3.24 6.22
Aug 3.01 2.83 3.09 8.35
Sep 3.13 3.06 3.23 5.13
Oct 3.03 2.93 3.25 9.71
Nov 2.80 2.73 2.86 4.64
Dec 2.86 2.78 3.04 8.67
Full forecast for 2028

Emergent BioSolutions information and performance

Emergent BioSolutions Address

400 PROFESSIONAL DR, SUITE 400, GAITHERSBURG, MD, US

Market Capitalization: 107 539 000 $

Market capitalization of the Emergent BioSolutions Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of EBS shares in the company outstanding by the market price of one share.

EBITDA: -70 700 000 $

EBITDA of Emergent BioSolutions is earnings before interest, income tax and depreciation of assets.

PE Ratio: None

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: 1.55

Price/earnings to growth

DPS: None

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: None

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: -14.85

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: 0.022
Quarterly Revenue Growth YOY: -0.162
Trailing PE: -

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: 7.94

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: 0.837

Enterprise Value (EV) /Revenue

EV To EBITDA: -1.652

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 52203000

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A



Related stocks from Healthcare sector

SCYNEXIS, Inc. (SCYX)
Align Technology, Inc. (ALGN)
bluebird bio, Inc. (BLUE)
Trevi Therapeutics, Inc. (TRVI)
Deciphera Pharmaceuticals, Inc. (DCPH)
Turning Point Therapeutics, Inc. (TPTX)
Cigna Corp. (CI)
Gritstone bio, Inc. (GRTS)
Charles River Laboratories International, Inc. (CRL)
Longeveron Inc. (LGVN)


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.


This website uses cookies to ensure you get the best experience on our website